SCHEMBL7974273

SCHEMBL7974273

CCc1nc(=O)c2c(ncn2Cc2ccc(C)cc2C)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
TP53 P04637 1/20 0.37
TSHR P16473 5/20 0.36
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
HPGD P15428 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
P2RX7 Q99572 1/20 0.34
PKM P14618 1/20 0.34
PKLR P30613 1/20 0.34
PARN O95453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988887 0.86 SMN1; SMN2 (0.46) SMN1; SMN2LMNAPOLBMAPTTP53
SCHEMBL7987439 0.83 CNOT7 (0.43) SMN1; SMN2LMNAMAPTHTTTP53
SCHEMBL7984380 0.82 CYP11B1 (0.40) SMN1; SMN2LMNAMAPTHTTTSHR
SCHEMBL7974269 0.82 TNF (0.44) TNFSMN1; SMN2LMNAPOLBMAPT
SCHEMBL7974262 0.82 ALDH1A1 (0.45) SMN1; SMN2LMNAPOLBMAPTHTT
SCHEMBL7984442 0.78 LMNA (0.42) LMNAPOLBTP53MEN1KMT2A
SCHEMBL7987963 0.78 CNOT7 (0.38) SMN1; SMN2HPGDALDH1A1PARNCNOT7
SCHEMBL7975254 0.77 CNOT7 (0.55) SMN1; SMN2POLBKMT2AHPGDALDH1A1
SCHEMBL7984530 0.75 HPGD (0.46) SMN1; SMN2HTTMEN1KMT2AHPGD
SCHEMBL7988132 0.75 CNOT7 (0.44) SMN1; SMN2LMNAHPGDALDH1A1PARN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed